» Articles » PMID: 35660032

Prolonging Survival in Advanced Esophageal Squamous Cell Carcinoma With Immune Checkpoint Inhibitors

Overview
Specialty Gastroenterology
Date 2022 Jun 6
PMID 35660032
Authors
Affiliations
Soon will be listed here.
Citing Articles

Body Composition and Clinical Outcomes in Esophageal Cancer Patients Treated with Immune Checkpoint Inhibitors.

Kosumi K, Baba Y, Hara Y, Wang H, Nomoto D, Toihata T Ann Surg Oncol. 2024; 31(6):3839-3849.

PMID: 38421531 DOI: 10.1245/s10434-024-15093-3.


Deciphering Treg cell roles in esophageal squamous cell carcinoma: a comprehensive prognostic and immunotherapeutic analysis.

Zhang P, Dong S, Sun W, Zhong W, Xiong J, Gong X Front Mol Biosci. 2023; 10:1277530.

PMID: 37842637 PMC: 10568469. DOI: 10.3389/fmolb.2023.1277530.